AzTrials
AzTrials

Intellectual Disabilities (F70-F79)VR-MIDNCT07249359

Virtual Reality for Dental Anxiety in Children With Mild Intellectual Disability

A study testing Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure in people with Intellectual Disabilities (F70-F79), run by Oasi Research Institute-IRCCS at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Virtual reality (VR) is a promising non-pharmacological approach to reduce dental anxiety in children with neurodevelopmental disorders. This randomized controlled trial compared a VR-based distraction intervention with conventional monitor-based distraction in children aged 11-15 years with mild intellectual… Read more about this study

Who is it for?
Ages 11 to 15 years
Conditions the study is for
Intellectual Disabilities (F70-F79)
What is being tested?
Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteItaly
Study dates
1 Feb 2025to 30 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 11-15; diagnosis of mild intellectual disability (DSM-5)
  • Moderate anxiety (Corah DAS 9-12)
  • ≥1 decayed tooth requiring conservative treatment under local anesthesia
  • Informed consent from parents/legal guardians

Who cannot join

  • no or slight anxiety
  • high or severe anxiety
  • visual disorders
  • neuromuscular comorbidities interfering with cooperation

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Ass. Oasi Maria SS

    Troina, EN, 94018

Other trials in Italy

About this study

Official title: Effect of Virtual Reality on Dental Anxiety in Children With Mild Intellectual Disability: A Randomized Controlled Trial

Virtual reality (VR) is a promising non-pharmacological approach to reduce dental anxiety in children with neurodevelopmental disorders. This randomized controlled trial compared a VR-based distraction intervention with conventional monitor-based distraction in children aged 11-15 years with mild intellectual disability and moderate dental anxiety undergoing conservative dental treatment.

Being tested
Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure, Control: Monitor-Based Distraction
Medical subject headings
Intellectual Disability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedureDevice

    immersive VR software delivered through Meta Quest 3® headset during dental procedure

  • Control: Monitor-Based DistractionDevice

    cartoon video displayed in front of dental chair

Study groups in NCT07249359
Study groupRoleWhat they receive
Virtual Reality DistractionExperimentalimmersive VR software delivered through Meta Quest 3® headset during dental procedure
Receives: Device: Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure
Control: Monitor-Based DistractionActive comparatorcartoon video displayed in front of dental chair
Receives: Device: Control: Monitor-Based Distraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Treatment success

    Number of patients with completion of restorative dental procedure under local anesthesia within 50 minutes and positive overall treatment experience (dichotomous: success vs. failure)

    Measured: Duration of procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2025
  2. Study start1 Feb 2025
  3. Primary completion30 Jun 2025
  4. Study completion30 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07249359
Sponsor's protocol ID
RC-2794677
Acronym
VR-MID
Status last verified
Nov 2025
First submitted
17 Nov 2025
Last updated
3 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Distraction - immersive VR software delivered through Meta Quest 3® headset during dental procedure in people with Intellectual Disabilities (F70-F79), run by Oasi Research Institute-IRCCS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Treatment success (time frame: Duration of procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in